Nevada | NonOpioidChoices

State Facts

931

Deaths or 63.6% of total overdose deaths involved opioids in 2024.¹

537,285

Claims or 5.18% of all Medicare Part D claims were for opioids in 2022 – an average of 55 per prescriber.²

40.1

Opioid Prescriptions were written for every 100 persons in Nevada in 2023.³

15,417

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$1,030,191,025.92

State Spending Recommendation

Funding for medical provider education and outreach regarding best prescribing practices for opioids, consistent with the 2016 CDC guidelines, including providers at hospitals (academic detailing

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective,  and individualized pain management throughout the continuum of care.

Co-Sponsors (119th)

Sen. Catherine Cortez Masto (D-NV)

2025 Introduced Relevant Legislation

SB 377

This bill requires public and private health insurance plans to cover non-opioid alternatives on equal terms with opioids, prohibiting insurers from imposing extra restrictions on those alternatives and ensuring patients can access them when deemed appropriate by their healthcare provider.

Introduced

03/17/2025

Plan Impact

Medicaid & Commercial

Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf